Capstone Investment Advisors, LLC Biodesix Inc Transaction History
Capstone Investment Advisors, LLC
- $35.4 Billion
- Q1 2025
A detailed history of Capstone Investment Advisors, LLC transactions in Biodesix Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 15,437 shares of BDSX stock, worth $6,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,437Holding current value
$6,174% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
47.7MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$3.31 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$2.44 Million0.03% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$2.29 Million3.25% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.64 Million0.63% of portfolio
-
Monashee Investment Management LLC Boston, MA4.05MShares$1.62 Million0.35% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $16M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...